Entourage Health to Host Second Quarter 2024 Financial Results Call
06 August 2024 - 9:41PM
Entourage Health Corp.
(TSX-V: ENTG) (OTCQX: ETRGF)
(FSE:4WE) ("Entourage" or the "Company"), a Canadian
producer and distributor of award-winning cannabis products,
announced today that the Company's second quarter 2024 financial
results will be released after market close on Monday, August 26,
2024. The Company will host a conference call to discuss the
results and provide an operational update and recap of achievements
on Tuesday, August 27, 2024.
Conference Call Details:
The conference call will be hosted by CEO and
Executive Chair George Scorsis and CFO Vaani Maharaj. Following the
opening remarks, management will be available to answer
questions.
Time: |
10:00 am Eastern Time |
Toll-Free Number: |
+1 (800)-267-6316 |
Conference ID: |
ETRGFQ2 |
Webcast: |
https://events.q4inc.com/attendee/382521020 |
|
|
Company Update
The Company announced earlier it was in breach
of certain financial covenants and other obligations under each of
its Senior Credit Agreement and Subordinated Credit agreements with
an affiliate of the LiUNA Pension Fund of Central and Eastern
Canada (“LPF”). The Company is working collaboratively with LPF to
agree on amended debt terms. As a positive step forward, the
Company received a renewed forbearance letter dated August 2, 2024,
waiving the Company’s breaches until October 8, 2024, subject to
the satisfaction or waiver of certain conditions.
About Entourage Health
Corp.
Entourage Health Corp. is the publicly traded
parent Company of Entourage Brands Corp., a licence holder
producing and distributing cannabis products for the medical and
adult-use markets. The Company owns and operates a fully licensed
26,000F sq. ft. Aylmer, ON processing facility. With its Starseed
Medicinal medical-centric brand, Entourage has expanded its
multi-channelled distribution strategy. Starseed's industry-first,
exclusive partnership with LiUNA, the largest construction union in
Canada, along with employers and union groups, complements
Entourage's direct sales to medical patients. Entourage's elite
adult-use product portfolio includes Color Cannabis, Saturday
Cannabis – and now Dime Bag and Syndicate – sold across eight
provincial distribution agencies. Exclusive Canadian producer and
distributor of award-winning U.S.-based wellness brand Mary's
Medicinals, sold in both medical and adult-use channels. In
addition, Entourage also entered into an exclusive agreement with
Irwin Naturals, a renowned nutraceutical and herbal supplement
formulator of branded wellness products sold across North
America.
Follow Entourage and its brands on:
LinkedIn
Instagram: Color Cannabis, Saturday Cannabis,
Dimebag
For additional information or investor or media
inquiries:Catherine FlamanSenior Director, Communications
& Corporate
Affairs416-910-0279catherine.flaman@entouragecorp.com
Forward Looking Information
This press release contains "forward-looking
information" within the meaning of applicable Canadian securities
legislation which are based upon Entourage's current internal
expectations, estimates, projections, assumptions and beliefs and
views of future events. Forward-looking information can be
identified using forward-looking terminology such as "expect",
"likely", "may", "will", "should", "intend", "anticipate",
"potential", "proposed", "estimate" and other similar words,
including negative and grammatical variations thereof, or
statements that certain events or conditions "may", "would" or
"will" happen, or by discussions of strategy.
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions, and views of future events which management believes
to be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance, or other statements that are not
statements of fact. Forward-looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry in Canada generally; the
ability of Entourage to implement its business strategies; the
COVID-19 pandemic; competition; crop failure; and other risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage’s disclosure documents filed with the
applicable Canadian securities' regulatory authorities on SEDAR+ at
www.sedarplus.ca. The risk factors and other factors noted in
the disclosure documents could cause actual events or results to
differ materially from those described in any forward-looking
information.